相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。T Cell Epitope Predictions
Bjoern Peters et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Regulatory T Cells Restrain Interleukin-2-and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells
Anna Sledzinska et al.
IMMUNITY (2020)
Stress- and ubiquitylation-dependent phase separation of the proteasome
Sayaka Yasuda et al.
NATURE (2020)
Role for ribosome-associated quality control in sampling proteins for MHC class I-mediated antigen presentation
Debora Broch Trentini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Pervasive functional translation of noncanonical human open reading frames
Jin Chen et al.
SCIENCE (2020)
Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides
Jamie R. Wangen et al.
ELIFE (2020)
Sublethal Radiation Affects Antigen Processing and Presentation Genes to Enhance Immunogenicity of Cancer Cells
Achamaporn Punnanitinont et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes
Chloe Chong et al.
NATURE COMMUNICATIONS (2020)
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Keisuke Yamamoto et al.
NATURE (2020)
Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
Alaknanda Adwal et al.
LIFE SCIENCE ALLIANCE (2020)
A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction
Shutao Mei et al.
BRIEFINGS IN BIOINFORMATICS (2020)
Immunoribosomes: Where's there's fire, there's fire
Jiajie Wei et al.
MOLECULAR IMMUNOLOGY (2019)
TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class Ilow cancers
Koen A. Marijt et al.
MOLECULAR IMMUNOLOGY (2019)
Translational Control in Cancer
Nathaniel Robichaud et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2019)
Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related Markers
Miseon Lee et al.
CANCER RESEARCH AND TREATMENT (2019)
Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin
J. Patrick Murphy et al.
ANALYTICAL CHEMISTRY (2019)
Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer
Mirco Compagnone et al.
HUMAN IMMUNOLOGY (2019)
Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance
Saptha Vijayan et al.
IMMUNOGENETICS (2019)
Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance
Jiajie Wei et al.
MOLECULAR CELL (2019)
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
Daisuke Ennishi et al.
CANCER DISCOVERY (2019)
MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series
Selma Ugurel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames
Damien J. Zanker et al.
JOURNAL OF IMMUNOLOGY (2019)
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Markus W. Loeffler et al.
GENOME MEDICINE (2019)
Stop-codon read-through arises largely from molecular errors and is generally nonadaptive
Chuan Li et al.
PLOS GENETICS (2019)
DeepLigand: accurate prediction of MHC class I ligands using peptide embedding
Haoyang Zeng et al.
BIOINFORMATICS (2019)
Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes
Andrea Castro et al.
BMC MEDICAL GENOMICS (2019)
The Translational Landscape of the Human Heart
Sebastiaan van Heesch et al.
CELL (2019)
DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade
Guo-Liang Chew et al.
DEVELOPMENTAL CELL (2019)
Ribosome Profiling: Global Views of Translation
Nicholas T. Ingolia et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2019)
Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses
Ting Wu et al.
NATURE COMMUNICATIONS (2019)
Histone Deacetylase Inhibition Sensitizes PD1 Blockade-Resistant B-cell Lymphomas
Xiaoguang Wang et al.
CANCER IMMUNOLOGY RESEARCH (2019)
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
Marian L. Burr et al.
CANCER CELL (2019)
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy
Michael Friedrich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion
Reshmi Tripathi et al.
ONCOIMMUNOLOGY (2019)
Comment on A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands
Zach Rolfs et al.
SCIENCE IMMUNOLOGY (2019)
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach et al.
NATURE (2019)
Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy
Diego Chowell et al.
NATURE MEDICINE (2019)
Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection
Wayne Paes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Nuclear processing of nascent transcripts determines synthesis of full-length proteins and antigenic peptides
Rodrigo Prado Martins et al.
NUCLEIC ACIDS RESEARCH (2019)
Mapping the MHC Class I-Spliced Immunopeptidome of Cancer Cells
Juliane Liepe et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells
Sebastian Montealegre et al.
FRONTIERS IN IMMUNOLOGY (2019)
Peptide Channeling: The Key to MHC Class I Immunosurveillance?
Jonathan W. Yewdell et al.
TRENDS IN CELL BIOLOGY (2019)
MHC Class-I Loss and Cancer Immune Escape Introduction
Federico Garrido
MHC CLASS-I LOSS AND CANCER IMMUNE ESCAPE (2019)
Survey of the translation shifts in hepatocellular carcinoma with ribosome profiling
Qin Zou et al.
THERANOSTICS (2019)
Alternative tumour-specific antigens
Christof C. Smith et al.
NATURE REVIEWS CANCER (2019)
Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells
Ting Sun et al.
JOURNAL OF CANCER (2019)
Complete motif analysis of sequence requirements for translation initiation at non-AUG start codons
Alexander J. Diaz de Arce et al.
NUCLEIC ACIDS RESEARCH (2018)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell et al.
SCIENCE (2018)
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Lu Huang et al.
CLINICAL CANCER RESEARCH (2018)
Translation initiation factors and their relevance in cancer
Columba de la Parra et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Quiescent Tissue Stem Cells Evade Immune Surveillance
Judith Agudo et al.
IMMUNITY (2018)
Influenza A Virus Negative Strand RNA Is Translated for CD8+ T Cell Immunosurveillance
Heather D. Hickman et al.
JOURNAL OF IMMUNOLOGY (2018)
Improved Ribo-seq enables identification of cryptic translation events
Florian Erhard et al.
NATURE METHODS (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Ribosome profiling of the retrovirus murine leukemia virus
Nerea Irigoyen et al.
RETROVIROLOGY (2018)
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing
Deng Pan et al.
SCIENCE (2018)
Protein Phase Separation: A New Phase in Cell Biology
Steven Boeynaems et al.
TRENDS IN CELL BIOLOGY (2018)
Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Catherine S. Grasso et al.
CANCER DISCOVERY (2018)
Selected HLA-B allotypes are resistant to inhibition or deficiency of the transporter associated with antigen processing (TAP)
Jie Geng et al.
PLOS PATHOGENS (2018)
Translation acrobatics: how cancer cells exploit alternate modes of translational initiation
Ashwin Sriram et al.
EMBO REPORTS (2018)
Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-1 Ligandome
Roman Mylonas et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Noncoding regions are the main source of targetable tumor-specific antigens
Celine M. Laumont et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands
Pouya Faridi et al.
SCIENCE IMMUNOLOGY (2018)
Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors
Jan Budczies et al.
GENES CHROMOSOMES & CANCER (2017)
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2017)
Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands
Jiajie Wei et al.
JOURNAL OF IMMUNOLOGY (2017)
MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies
J. Patrick Murphy et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Translation from unconventional 5′ start sites drives tumour initiation
Ataman Sendoel et al.
NATURE (2017)
Identification of essential genes for cancer immunotherapy
Shashank J. Patel et al.
NATURE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman et al.
NATURE COMMUNICATIONS (2017)
TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer
Agnes Ling et al.
ONCOIMMUNOLOGY (2017)
MHC-I Genotype Restricts the Oncogenic Mutational Landscape
Rachel Marty et al.
CELL (2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan et al.
CELL (2017)
Properties of the tapasin homologue TAPBPR
Andreas Neerincx et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
The cytotoxic T cell proteome and its shaping by the kinase mTOR
Jens L. Hukelmann et al.
NATURE IMMUNOLOGY (2016)
Cathepsin G-mediated proteolytic degradation of MHC class I molecules to facilitate immune detection of human glioblastoma cells
David Palesch et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Kinetic Analysis of Protein Stability Reveals Age-Dependent Degradation
Erik McShane et al.
CELL (2016)
HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
Hong Zheng et al.
CLINICAL CANCER RESEARCH (2016)
Role of ribosomal protein mutations in tumor development (Review)
Kaveh M. Goudarzi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
MHC class I-associated peptides derive from selective regions of the human genome
Hillary Pearson et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Presentation of Cryptic Peptides by MHC Class I Is Enhanced by Inflammatory Stimuli
Sharanya Prasad et al.
JOURNAL OF IMMUNOLOGY (2016)
The ribosome-engaged landscape of alternative splicing
Robert J. Weatheritt et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
NLRC5/MHC class I transactivator is a target for immune evasion in cancer
Sayuri Yoshihama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Translation from the 5′ untranslated region shapes the integrated stress response
Shelley R. Starck et al.
SCIENCE (2016)
A large fraction of HLA class I ligands are proteasome-generated spliced peptides
Juliane Liepe et al.
SCIENCE (2016)
Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer
T. Colangelo et al.
CELL DEATH & DISEASE (2016)
The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells
T. Colangelo et al.
CELL DEATH & DISEASE (2016)
The ribosome-engaged landscape of alternative splicing
Robert J. Weatheritt et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
Ellen Stelloo et al.
ONCOTARGET (2016)
Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells
Madleen Giese et al.
ONCOTARGET (2016)
Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway
Emilie Duvallet et al.
ONCOIMMUNOLOGY (2016)
The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35-specific T-cell recognition
Martin Keller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Codon Bias as a Means to Fine-Tune Gene Expression
Tessa E. F. Quax et al.
MOLECULAR CELL (2015)
HLA-B polymorphisms and intracellular assembly modes
Malini Raghavan et al.
MOLECULAR IMMUNOLOGY (2015)
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
K. V. Woan et al.
MOLECULAR ONCOLOGY (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
Sachet A. Shukla et al.
NATURE BIOTECHNOLOGY (2015)
Aire controls gene expression in the thymic epithelium with ordered stochasticity
Matthew Meredith et al.
NATURE IMMUNOLOGY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma
Sherille D. Bradley et al.
CANCER IMMUNOLOGY RESEARCH (2015)
HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
David M. Woods et al.
CANCER IMMUNOLOGY RESEARCH (2015)
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma
Carsten Linnemann et al.
NATURE MEDICINE (2015)
Modified ribosome profiling reveals high abundance of ribosome protected mRNA fragments derived from 3′ untranslated regions
Teemu P. Miettinen et al.
NUCLEIC ACIDS RESEARCH (2015)
Epigenetic Changes within the Promoter Regions of Antigen Processing Machinery Family Genes in Kazakh Primary Esophageal Squamous Cell Carcinoma
Ilyar Sheyhidin et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Computational approach for calculating the probability of eukaryotic translation initiation from ribo-seq data that takes into account leaky scanning
Audrey M. Michel et al.
BMC BIOINFORMATICS (2014)
Cognate Peptide-MHC Complexes Are Expressed as Tightly Apposed Nanoclusters in Virus-Infected Cells To Allow TCR Crosslinking
Maria Ferez et al.
JOURNAL OF IMMUNOLOGY (2014)
Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors
Luis C. Anton et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
The nature and extent of contributions by defective ribosome products to the HLA peptidome
Dmitry Bourdetsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Effect of Proteasome Inhibition on the Generation of the Human Leukocyte Antigen (HLA) Peptidome
Elena Milner et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
A Cotranslational Ubiquitination Pathway for Quality Control of Misfolded Proteins
Feng Wang et al.
MOLECULAR CELL (2013)
Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway
Sebastien Apcher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Kinetics of Antigen Expression and Epitope Presentation during Virus Infection
Nathan P. Croft et al.
PLOS PATHOGENS (2013)
Ribosome profiling reveals pervasive and regulated stop codon readthrough in Drosophila melanogaster
Joshua G. Dunn et al.
ELIFE (2013)
The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation
Florencia Cano et al.
EMBO JOURNAL (2012)
Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters
Xiuju Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA
Brian P. Dolan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Leucine-tRNA Initiates at CUG Start Codons for Protein Synthesis and Presentation by MHC Class I
Shelley R. Starck et al.
SCIENCE (2012)
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
Damian B. Yap et al.
BLOOD (2011)
Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes
Nicholas T. Ingolia et al.
CELL (2011)
Post-proteasomal and proteasome-independent generation of MHC class I ligands
Peter van Endert
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation
Sebastien Apcher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Bystander killing of cancer requires the cooperation of CD4+ and CD8+ T cells during the effector phase
Andrea Schietinger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action
Avital Lev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer
Q. Ye et al.
TISSUE ANTIGENS (2010)
Interaction of Bap31 and MHC Class I Molecules and Their Traffic Out of the Endoplasmic Reticulum
Fumiyoshi Abe et al.
JOURNAL OF IMMUNOLOGY (2009)
Systematic Characterisation of Cellular Localisation and Expression Profiles of Proteins Containing MHC Ligands
Agnieszka S. Juncker et al.
PLOS ONE (2009)
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells
A. Nazmul H. Khan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The turnover kinetics of major histocompatibility complex peptides of human cancer cells
E Milner et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
An antigenic peptide produced by peptide splicing in the proteasome
N Vigneron et al.
SCIENCE (2004)
Immune recognition of a human renal cancer antigen through post-translational protein splicing
K Hanada et al.
NATURE (2004)
Comparative immunopeptidomics of humans and their pathogens
S Istrail et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Organization of mammalian cytoplasm
A Hudder et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Chromatin repression by COUP-TFII and HDAC dominates activation by NF-κB in regulating major histocompatibility complex class I transcription in adenovirus tumorigenic cells
BW Zhao et al.
VIROLOGY (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Expression of HLA class I antigens and restoration of antigen-specific ctl response in melanoma cells following 5-aza-2′-deoxycytidine treatment
A Serrano et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas
Y Nie et al.
CARCINOGENESIS (2001)
Clustering of peptide-loaded MHC class I molecules for endoplasmic reticulum export imaged by fluorescence resonance energy transfer
T Pentcheva et al.
JOURNAL OF IMMUNOLOGY (2001)
Selective export of MHC class I molecules from the ER after their dissociation from TAP
ET Spiliotis et al.
IMMUNITY (2000)
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
U Schubert et al.
NATURE (2000)
Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer
LA Koopman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
